5. A Good Day to Die Hard (20th Century-Fox) Week 2 - Last Weekend: #1
$10,000,000 (-) in 3,555 theaters (+2); PSA: $2,813; Cumulative: $51,802,000
This is an embarrassing fall around 60% for this now officially underperforming older-action starrer sequel, from #1 to #5 in a weak period. Only in its second week, this is running out of steam quickly. Combined with just OK foreign grosses, this looks like is could struggle to reach $250 million worldwide - way below hopes for a film that cost Fox $90 million+ before getting into marketing expenses.
This film was the first "tentpole" multiple-quadrant film to be released this year. Its mediocre performance is another sign of problems for studios and theaters alike post-holidays.
What comes next: Suggestion of more sequels last week looks premature, at least at this expense to make.
6. Dark Skies (Weinstein) NEW - Cinemascore: C+; Metacritic score: 48
$8,850,000 in 2,313 theaters; PSA: $3,826; Cumulative: $8,850,000
After a seriies of low budget horror openings that easily surpassed $10 million so far this year, this will fall short. But with a $3.5 million budget for its producer (Jason Blum, whose credits include the "Paranormal" series, "Sinister" and "The Bay," as well as a hand in "The Reader") and a deal with Weinstein that has them putting up marketing, this gross for those parties isn't a disaster, even if lower than hoped.
For all of the late-year Oscar-fueled success Weinstein has had, the one crucial element the company has lacked in recent years has been the strong backup (and often best grosses for the company) of Dimension division films. Most of these have been in-house rather than side deals like this (a sci-fi horror story about a mother shielding her kids from aliens).
Director Scott Stewart broke into the horror genre with "Legion" and "Priest," both from Sony's Screen Gems unit, both opening close to double or better. The latter however had a $60 million budget and capped at under $30 million in the U.S. A breakeven low-cost effort like this is preferable for all involved.
For lead actress Keri Russell, quiet mainly since her breakout indie success "Waitress," this is a brief interlude before her recent Sundance success "Austenland" hits theaters later this year.
What comes next: Not much more than a second week looks in store for this.
7. Silver Linings Playbook (Weinstein) Week 15 - Last Weekend: #8
$6,051,000 (-3%) in 2,012 theaters (-190); PSA: $3,007; Cumulative: $107,476,000
Way ahead at this point of the other Oscar contenders still in release, with its PSA up a bit with some minor theater loss, no film has ridden the nomination curve better (at least in terms of gross -- the marketing expense of this release plan spread over so many weeks with diminishing film rental made it less lucrative).
What comes next: Even without major Oscar wins tonight this has some life left, but a quite possible Best Actress win and maybe more could keep this in theaters for weeks more.
8. Warm Bodies (Lionsgate) Week 4 - Last Weekend: #5
$4,750,000 (-46%) in 2,644 theaters (-253); PSA: $1,797; Cumulative: $58,168,053
This teenage/female appeal vampire romcom continues to perform well as one of the pleasant surprises of early 2013. Though hardly "Twilight," it again reinforces Lionsgates reputation for finding success in another variation in the horror genre field.
What comes next: This could make it to $75 million domestic, with then the rest of world making this $30 million budget film from Lionsgates' Summit division a solid investment.
9. Side Effects (Open Road) Week 3 - Last Weekend: #7
$3,511,000 (-41%) in 2,070 theaters (-535); PSA: $1,696; Cumulative: $25,254,000
Holding up a bit better than some recent releases, this now looks like it will end up a bit ahead of what its sub-$10 million weekend suggested.
What comes next: From director Steven Soderbergh at least, nothing imminent, and perhaps not for a long time if ever as his hiatus (and possible retirement) commences.
10. Beautiful Creatures (Warner Bros.) Week 2 - Last Weekend: #6
$3,410,000 (-55%) in 2,950 theaters (unchanged); PSA: $1,156; Cumulative: $16,372,000
At least it didn't drop the most of any of last week's openings.
What comes next: Two and out for many of its theaters for this latest flop from Warners.